Medical Microbiology and Immunology

, Volume 187, Issue 1, pp 23–42 | Cite as

Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain

  • Brian J. Balin
  • Hervé C. Gérard
  • E. James Arking
  • Denah M. Appelt
  • Patrick J. Branigan
  • J. Todd Abrams
  • J. A. Whittum-Hudson
  • A. P. Hudson
ORIGINAL INVESTIGATION

Abstract

We assessed whether the intracellular bacterium Chlamydia pneumoniae was present in post-mortem brain samples from patients with and without late-onset Alzheimer's disease (AD), since some indirect evidence seems to suggest that infection with the organism might be associated with the disease. Nucleic acids prepared from those samples were screened by polymerase chain reaction (PCR) assay for DNA sequences from the bacterium, and such analyses showed that brain areas with typical AD-related neuropathology were positive for the organism in 17/19 AD patients. Similar analyses of identical brain areas of 18/19 control patients were PCR-negative. Electron- and immunoelectron-microscopic studies of tissues from affected AD brain regions identified chlamydial elementary and reticulate bodies, but similar examinations of non-AD brains were negative for the bacterium. Culture studies of a subset of affected AD brain tissues for C. pneumoniae were strongly positive, while identically performed analyses of non-AD brain tissues were negative. Reverse transcription (RT)-PCR assays using RNA from affected areas of AD brains confirmed that transcripts from two important C. pneumoniae genes were present in those samples but not in controls. Immunohistochemical examination of AD brains, but not those of controls, identified C. pneumoniae within pericytes, microglia, and astroglia. Further immunolabelling studies confirmed the organisms' intracellular presence primarily in areas of neuropathology in the AD brain. Thus, C. pneumoniae is present, viable, and transcriptionally active in areas of neuropathology in the AD brain, possibly suggesting that infection with the organism is a risk factor for late-onset AD.

Key words Chlamydia Alzheimer's disease Inflammation Dementia Infection 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • Brian J. Balin
    • 1
  • Hervé C. Gérard
    • 2
  • E. James Arking
    • 1
  • Denah M. Appelt
    • 1
  • Patrick J. Branigan
    • 2
  • J. Todd Abrams
    • 3
  • J. A. Whittum-Hudson
    • 4
  • A. P. Hudson
    • 2
  1. 1.Department of Pathology and Laboratory Medicine, MCP-Hahnemann School of Medicine, Allegheny University of the Health Sciences, New College Building, Broad and Vine Streets, Philadelphia, PA 19102, USAUS
  2. 2.Department of Microbiology and Immunology, MCP-Hahnemann School of Medicine, Allegheny University of the Health Sciences, 2900 Queen Lane, Philadelphia, PA 19129, USA; and Medical Research, Department Veterans Affairs Medical Center, University and Woodland Avenues, Philadelphia, PA 19104, USAUS
  3. 3.Department of Dermatology, MCP-Hahnemann School of Medicine, Allegheny University of the Health Sciences, New College Building, Broad and Vine Streets, Philadelphia, PA 19102, USAUS
  4. 4.Ocular Immunology Laboratories, Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21287, USATP

Personalised recommendations